Grażyna Płucienniczak

Title: Grażyna Płucienniczak: Innovator in Influenza Virus Research

Introduction

Grażyna Płucienniczak is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for combating influenza viruses. His work has implications for both human and animal health.

Latest Patents

Płucienniczak holds a patent for "Monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses and their uses, hybridomas producing said antibodies, compositions and diagnostic kits." This invention focuses on monoclonal antibodies that target hemagglutinin of H5-serotype influenza viruses. The antibodies selected from the group comprising G-1-31-22, G-2-14-10, G-5-32-5, G-6-42-42, G-7-24-17, and G-7-27-18 have broad applications in immunoprophylaxis and immunotherapy. The invention also includes hybridomas that produce these antibodies, as well as diagnostic kits for detecting H5-serotype influenza viruses in biological samples.

Career Highlights

Throughout his career, Płucienniczak has worked with prominent institutions such as Sieć Badawcza Łukasiewicz—Instytut Biotechnologii i Antybiotyków and Uniwersytet Gdański. His research has focused on the development of innovative solutions to combat viral infections, showcasing his commitment to advancing medical science.

Collaborations

Płucienniczak has collaborated with notable colleagues, including Violetta Sączyńska and Violetta Cecuda-Adamczewska. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Grażyna Płucienniczak is a distinguished inventor whose work in monoclonal antibodies has the potential to significantly impact the field of virology. His contributions to influenza virus research highlight the importance of innovation in biotechnology.